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Abstract
Motion sickness is a complex condition that includes both overt signs (e.g., vomiting) and more covert symptoms (e.g.,
anxiety and foreboding). The neural pathways that mediate these signs and symptoms are yet to identified. This study
mapped the distribution of c-fos protein (Fos)-like immunoreactivity elicited during a galvanic vestibular stimulation
paradigm that is known to induce motion sickness in felines. A principal components analysis was used to identify networks
of neurons activated during this stimulus paradigm from functional correlations between Fos labeling in different nuclei.
This analysis identified five principal components (neural networks) that accounted for greater than 95% of the variance in
Fos labeling. Two of the components were correlated with the severity of motion sickness symptoms, and likely participated
in generating the overt signs of the condition. One of these networks included neurons in locus coeruleus, medial, inferior
and lateral vestibular nuclei, lateral nucleus tractus solitarius, medial parabrachial nucleus and periaqueductal gray. The
second included neurons in the superior vestibular nucleus, precerebellar nuclei, periaqueductal gray, and parabrachial
nuclei, with weaker associations of raphe nuclei. Three additional components (networks) were also identified that were not
correlated with the severity of motion sickness symptoms. These networks likely mediated the covert aspects of motion
sickness, such as affective components. The identification of five statistically independent component networks associated
with the development of motion sickness provides an opportunity to consider, in network activation dimensions, the
complex progression of signs and symptoms that are precipitated in provocative environments. Similar methodology can
be used to parse the neural networks that mediate other complex responses to environmental stimuli.
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Introduction
Vomiting is usually considered to be a protective reflex to rid
the body of ingested toxins. However, this response is also elicited
following surgery or exposure to radiation, during cancer
chemotherapy or pregnancy, and even as a consequence of some
psychological stimuli [1,2]. Vestibular stimulation can also result
in emesis, particularly during conditions where sensory inputs
provide contradictory information regarding body position in
space [3,4]. It is generally assumed that emesis, despite its
triggering mechanism, is mediated through a ‘‘final common
pathway’’ [4–8]. The same output pathways that produce
vomiting in response to toxins are thus also presumably involved
in generating motion sickness-related emesis. One strong piece of
evidence to support the final common pathway hypothesis is the
existence of broad-spectrum antiemetics, such as neurokinin-1
(NK1) receptor antagonists, that prevent vomiting despite the
provocation [9–15]. NK1 receptor antagonists are effective in a
variety of species, including humans, musk shrews, ferrets, dogs,
and cats, suggesting that the neural pathways that produce
vomiting are similar across emetic animals. However, many
animals, including the most commonly used species in biomedical
research (rodents and rabbits), lack the capacity to vomit [16].
This is due both to reduced muscularity of the diaphragm and a
stomach geometry that is not well structured for moving contents
towards the esophagus in non-emetic animals. In addition, the
brainstem circuitry that regulates the respiratory muscle contrac-
tions that result in vomiting differs between emetic and non-emetic
animals [16,17].
The sensation of nausea usually precedes vomiting, and is
complex [4], as it includes epigastric awareness and discomfort
along with anxiety and foreboding regarding the emesis that could
ensue [18–20]. Some of the symptoms that occur during motion
sickness, such as pallor and cold sweating, have been associated
with the stress accompanying the condition [5]. Studies conducted
in a variety of animal species have attempted to determine the
brain regions that mediate nausea and vomiting by mapping the
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distribution of c-fos protein (Fos)-like immunoreactivity elicited
during this behavior [21–28]. c-fos is an immediate-early gene that
is rapidly expressed in response to neuronal activation. After being
synthesized in the cytoplasm, Fos is quickly translocated to the
nucleus where, with the Jun protein, it forms a heterodimer that
regulates the expression of other genes [29,30]. As such, Fos
expression indicates that a neuron is activated during a particular
response. However, most previous experiments that included
emetic stimuli only considered Fos distribution in a restricted
region of the brainstem such as nucleus tractus solitarius (NTS)
[26,28,31] or circumscribed areas of the caudal medulla
[21,23,24,27]. Furthermore, only two studies have mapped Fos
expression during motion sickness [23,24]. Both studies were
conducted on shrews, which were placed on a tabletop shaker to
stimulate the vestibular system, and limited the mapping of Fos to
NTS and the adjacent reticular formation.
The goal of the present experiment was to perform a
comprehensive analysis of the distribution of Fos immunoreactivity
during vestibular-elicited nausea and emesis. Felines were used as
the model animal during these studies, since most neurophysio-
logical experiments probing the neural mechanisms that produce
vomiting have been conducted in cats [2,27,32–53]. The cat is a
species for which there is extensive background information
regarding the vestibular and respiratory control systems [54–58].
There are limited data about either the vestibular system or
respiratory regulation in other emetic animals, including dogs,
shrews and ferrets. Although nonhuman primates have been
extensively employed in studies of the vestibular system, little work
in these animals has addressed the neural mechanisms that
regulate respiratory muscle contractions. Consequently, cats were
the most appropriate emetic animals to be employed in these
experiments.
To evoke motion sickness, 90u out-of-phase galvanic stimulation
of the two labyrinths was delivered [59,60]. Prior studies have
shown that this regimen effectively produces emesis and related
prodromal symptoms in a subset of animals by generating a novel
pattern of vestibular inputs. However, unlike the complex motion
stimuli required to evoke motion sickness [61–78], this method
does not stimulate nonlabyrinthine receptors [59,60]. Thus, use of
galvanic electrical stimulation in these experiments discounted the
possibility that Fos labeling was related to stimulation of receptors
whose inputs were unrelated to the generation of motion sickness,
such as those activated by fluid shifts in the body. Due to the
possibility that different animals might have distinct responses
during stimulation, with some focused on the stress component of
motion sickness and others focused on epigastric awareness and
discomfort, we also considered whether the pattern of Fos
immunoreactivity was matched to the particular signs and
symptoms that each animal expressed. Furthermore, our initial
studies indicated that brainstem regions containing serotoninergic
neurons exhibited high levels of Fos immunoreactivity during
galvanic vestibular stimulation, so we additionally performed dual-
labeling immunohistochemistry to detect Fos and tryptophan
hydroxylase-2 (TPH2), the brain-specific isoform of the enzyme
responsible for the initial and rate-limiting step in serotonin
synthesis [79].
Materials and Methods
All experimental procedures conformed to the National
Research Council Guide for the Care and Use of Laboratory Animals
and were approved by the University of Pittsburgh’s Institutional
Animal Care and Use Committee. Data were collected from 10
purpose-bred adult cats (Liberty Research, Waverly, NY) of either
sex, weighing 2.4 to 4.6 kg at the conclusion of the experiment.
Information about the animals is provided in Table 1.
Animals were brought to the testing room daily for 29–66 days
(median of 50 days), for acclimation to the environment and the
investigators. During this period, animals were also gradually
conditioned for 90 min of restraint in a vinyl bag that
encompassed the limbs and torso. We found that animals adapted
more readily to restraint when held by an investigator during the
experimental session. The same individual handled a particular
animal during the course of the experiment, from initial
acclimation through the final session when labyrinthine stimula-
tion and then euthanasia were performed. During each session, the
laboratory was dark and quiet to avoid startling the animal.
Following daily restraint periods, animals were allowed to play in
the testing room and were offered a food reward, to further
reinforce that the environment was not threatening.
Surgical Procedures
Midway through the acclimation period, an aseptic surgical
procedure was performed in a dedicated operating suite to implant
stimulating electrodes adjacent to the labyrinth on each side.
During the surgery, animals were initially anesthetized using an
intramuscular injection of ketamine (20 mg/kg) and acepromazine
(0.2 mg/kg), an endotracheal tube was inserted, and anesthesia
Table 1. Characteristics about the animals used in these experiments, as well as the maximal voltage delivered to the labyrinths to
induce motion sickness and the period of acclimation to experimental conditions prior to the stimulation session.
Animal Number Maximum Stimulation Voltage Acclimation Period (days) Weight at Perfusion (kg) Gender
C39 3 V 31 4.6 Male
C52 4 V 34 4.1 Female
C15 3 V 56 4.0 Male
C62 3 V 29 2.4 Female
C64 5 V 44 3.3 Female
C02 5 V 64 2.5 Female
C20 5 V 67 4.0 Male
C41 5 V 30 4.2 Male
C83 0 V 58 4.0 Male
C84 0 V 66 3.8 Male
doi:10.1371/journal.pone.0086730.t001
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was maintained using 1–2% isoflurane vaporized in O2. The
tympanic bulla was opened using a ventrolateral approach. A
silver ball electrode with a tip diameter of ,0.6 mm was secured
using dental cement to the round window, and a second electrode
was attached ,5 mm away, adjacent to the promontory of the
tympanic cavity. The electrodes were insulated except at the tip
and attached to Cooner wire, which was led underneath the skin
to the top of the head and soldered to a connector. The connector
was subsequently attached to the skull using dental cement. After
this surgery, animals received antibiotics (amoxicillin, two 50-mg
oral doses per day) for 10 days, and analgesia (fentanyl
transdermal system, 25 mg/h; Janssen Pharmaceutical Products,
Titusville, NJ) for 72 h. The final stimulation session occurred 7–
41 days (median of 19 days) following the surgical implantation of
electrodes.
Labyrinthine Stimulation and Euthanasia
During acclimation periods after the implantation of electrodes,
the stimulator was attached to the head-mounted connector via a
cable, although no voltage was delivered, to mimic conditions
during the final stimulation session. In the final session, 0.5 Hz
sinusoidal galvanic stimulation was provided through the elec-
trodes to the two labyrinths; the sine waves delivered to the left
and right sides were 90u out-of-phase. Voltage sinusoids were
generated by a Micro1401 mk 2 data acquisition system controlled
by Spike2 version 6 software (Cambridge Electronic Design,
Cambridge, UK). We began the session by delivering 1 V stimuli,
and the intensity was gradually increased over the next few
minutes to a level that generated nystagmus and sinusoidal head
movements. The maximal voltage employed was 3 V for two
animals, 4 V for one animal, and 5 V for four animals (see
Table 1). However, 5 V stimuli elicited little perceptible response
in two of the animals (C20 and C41). The other two animals (C83
and C84) served as controls, and were connected to the stimulator
but no current was delivered through the electrodes. The finding
that symptom severity was not correlated with the stimulus
intensities delivered is not surprising. It is established that
individuals have varying susceptibility for motion sickness, and
that motion sickness symptoms vary between individuals [3–5].
Throughout the stimulation period, the animals were carefully
monitored, and the presence of the following behaviors was
scored: sinusoidal head roll, nystagmus, sinusoidal limb movement
(periodically observed by unzipping the restraint bag), licking,
retching, salivation, sinusoidal pinna movements, panting, defe-
cation, urination, sedation, vocalization, or thrashing in the
restraint bag (interpreted as an attempt to escape the stimulus).
If the latter two behaviors persisted for more than a few seconds,
the stimulus intensity was decreased until they abated. When
scoring behaviors, we noted whether they were overt or just
weakly perceptible. A semiquantitative, cumulative behavioral
score was also generated for each animal by assigning animals with
overt symptoms in a particular category a score of 2, and those
with weak symptoms a score of 1. These scores were then added
for the 13 behaviors monitored, as indicated in Table 2.
After 90 minutes, stimulation was discontinued, and the animals
were released from restraint and allowed to ambulate in the
laboratory for 60 minutes, as during the acclimation period, but
were not provided food or water. This post-stimulation period
allowed for the expression of Fos by neurons that were activated
during stimulation. The animals with the most profound responses
to stimulation typically remained sedentary during the recovery
period. Subsequently, animals were anesthetized using ketamine
(15 mg/kg) and acepromazine (1 mg/kg) injected intramuscularly,
followed by pentobarbital sodium (40 mg/kg) injected intraperi-
toneally. After verifying the absence of nociceptive reflexes, the
animals were perfused transcardially with 1 liter of heparinized
saline followed by 2 liters of 4% paraformaldehyde-lysine-
periodate fixative [80].
Tissue Processing
The brainstem was removed, postfixed 1–2 days in 4uC
paraformaldehyde-lysine-periodate, and cryoprotected in 30%
sucrose in 0.1 M phosphate-buffered saline (PBS) for 2 days.
Sections were cut at a thickness of 40 mm using a freezing
microtome and collected in six bins of cryoprotectant [81].
Procedures for Fos immunohistochemistry were adapted from a
protocol supplied by Dr. Charles Horn [22,82]. Two wells of
sections were rinsed in PBS to remove cryoprotectant, and then a
sequence of incubation steps was done in 1% sodium borohydride
in PBS, 0.3% hydrogen peroxide in PBS, and 5% normal goat
serum (NGS) in PBS containing 0.2% triton X-100 (PBS-TX),
with rinses between each step. Subsequently, sections were
incubated for 24 h at room temperature with gentle agitation in
1:5000 rabbit polyclonal anti-Fos antibody (sc-52; Santa Cruz
Biotechnology, Santa Cruz, CA) or 1:1000 mouse monoclonal
anti-Fos antibody (sc-8047; Santa Cruz Biotechnology) containing
1% NGS in PBS. Following rinses in PBS, sections were placed in
1:1000 biotinylated secondary antibody (Jackson ImmunoRe-
search Laboratories, West Grove, PA) for 3 h at room temperature
with gentle agitation. Sections were then rinsed twice in PBS-TX
and once in PBS, and then incubated in ABC reagent (Vector
Laboratories, Burlingame, CA) for three hours. After rinsing in 0.1
M acetate buffer, sections were placed in 3,39-diaminobenzidine
(5 mg/ml in 175 mM acetate–10 mM imidazole buffer, pH 7.4)
with nickel sulfate (25 mg/ml) for 0.5–1 min for the chromogen
reaction. Sections were then mounted on gelatin-coated slides,
cleared in ascending concentrations of ethanol followed by three
changes of xylene, and coverslipped with Cytoseal 60 (VWR
Scientific, West Chester, PA) or DPX (Sigma-Aldrich, St Louis,
MO). One bin of sections was counterstained with neutral red for
identification of cytoarchitecture.
A third bin of tissue from all the cases except the unstimulated
controls (animals C83 and C84) was processed for dual localization
of Fos and TPH2. As a first step, tissue was processed as described
above using mouse monoclonal anti-Fos antibody. After complet-
ing the chromagen reaction to visualize Fos as a blue-black
reaction product in the cell nuclei, sections were rinsed in PBS,
and avidin-biotin immunoperoxidase techniques [83] were used to
detect TPH2-containing neurons. A 1:2000 concentration of
rabbit anti-TPH2 antibody (supplied by the laboratory of Dr.
Stanley Watson at the University of Michigan) was employed in
the analysis; we have previously described the specificity of this
antibody in detecting serotoninergic neurons in cats [84].
Subsequently, sections were mounted onto slides and coverslipped
as described above.
Tissue Analysis
Following an initial qualitative analysis, 10 or more sections
from each animal were selected for quantitative analysis of the
distribution of Fos immunoreactivity. The distance of each section
anterior (A) or posterior (P) to stereotaxic zero was determined by
reference to Berman’s atlas [85]. The following brainstem levels
were included in the quantitative analysis: P16, through the
commissural nucleus tractus solitarius (NTS); P13.5, through the
obex; P12.5, through the rostral NTS; P9.5, through the inferior
vestibular nucleus and caudal aspect of the medial vestibular
nucleus; P7.5, through the lateral vestibular nucleus; P5.5, through
the superior vestibular nucleus; P4, through the parabrachial
Motion Sickness Circuitry
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nucleus; P2, through the caudal aspect of the inferior colliculus;
P1, through the caudal periaqueductal gray; A2, through the
rostral periaqueductal gray. Sections were photographed using a
4X objective of a Nikon Eclipse E600N photomicroscope
equipped with a Spot RT monochrome digital camera (Diagnostic
Instruments, Sterling Heights, MI) and MetaMorph imaging
software (Universal, Downingtown, PA). Montages of images were
assembled using PTGui-Pro photostitching software (New House
Internet Services B–V, The Netherlands). These montages, in
conjunction with observations of sections at high magnification,
were used to generate counts of labeled cells in target areas, as well
as plots of the locations of labeled cells. These plots provided the
data utilized in subsequent statistical analyses.
When analyzing sections processed for co-localization of Fos
and TPH2, we counted the number of single- and double-labeled
cells in regions of every section containing TPH2-postive neurons
(37–65 sections/animal, median of 48 sections/animal). For this
analysis, the following divisions of the raphe nuclei were
considered, as defined in a previous manuscript [84]: raphe
obscurus, raphe pallidus, raphe magnus, and the medial and
lateral regions of the dorsal raphe nucleus.
Statistical Analysis
Principal component analysis, conducted using Systat 11 (Systat
Software, Chicago, IL), was used to identify a set of statistically
independent (orthogonal) principal components that are sufficient
to explain the numbers of Fos labeled cells in 23 sampled nuclear
or subnuclear groups. The analysis was performed on the
correlation matrix. An equamax rotation was used as a
compromise of varimax and quartimax criteria, which minimizes
both the number of neural structures (variables) that load highly
on a component (network) and the number of components
(networks) needed to explain the behavior of a neural structure
(variable). The standardized component scores were calculated for
each subject.
Results
Table 2 provides details about behaviors exhibited by the
animals during the stimulation session. Throughout the period of
galvanic vestibular stimulation, three of the animals (C39, C52,
C15) displayed motor responses characteristic of activation of
labyrinthine receptors (sinusoidal head movement at the frequency
of the stimulus and nystagmus), as well as prodromal signs of
vomiting (periods of retching, copious salivation, frequent licking,
panting). At the end of the session, two of the three animals were
found to have defecated in the restraint bag; the watery diarrhea
was suggestive of an acute stress effect on gastrointestinal motility
[86]. The cumulative behavioral score for these three animals
ranged from 12–20 (see Table 2), and they were classified as
having strong autonomic responses to labyrinthine stimulation
(response type 1). Three other animals (C62, C64, C02) exhibited
overt behaviors indicating that the vestibular system was activated
by the stimulus, particularly sinusoidal head roll at the frequency
of the stimulus, although only one or two potential indicators of
motion sickness were evident for each animal (see Table 2). These
three animals had behavioral scores of 5–7, and were classified as
having response type 2. Two other animals (C20 and C41) had
little motor response to galvanic vestibular stimulation, although
both animals slept throughout most of the stimulation session; their
somnolence could have been a consequence of the stimulus. These
two animals were grouped with two control animals that were not
stimulated as having response type 3. The cumulative behavioral
scores for type 3 animals ranged from 0–4.
Expression of Fos by Brainstem Neurons Following
Galvanic Vestibular Stimulation
Maps of the locations of Fos-labeled neurons in animals with a
strong autonomic response are provided in Fig. 1, whereas Fig. 2
shows the locations of Fos labeling in response type 3 animals.
Photomicrographs of Fos-labeled neurons from a response type 1
animal are provided in Fig. 3. Fig. S1 also allows for a comparison
of Fos labeling in several brainstem regions containing serotonin-
Table 2. Behaviors exhibited by animals during galvanic vestibular stimulation: A, sinusoidal head roll at the frequency of the
stimulus; B, nystagmus; C, frequent licking; D, retching; E, excessive salivation; F, sinusoidal pinna movement at the frequency of
the stimulus; G, vocalization; H, panting; I, thrashing in the restraint bag, presumably as an attempt to escape the stimulus; J,
defecation during the stimulation session; K, urination during the stimulation session; L, sinusoidal limb movements at the
frequency of the stimulus; M, sedation (sleeping during the majority of the stimulation session).
Animal
Classification
(Score sum) A B C D E F G H I J K L M
C39 1 (20) ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
C52 1 (20) ++ ++ ++ ++ ++ ++ ++ ++ ++ + +
C15 1 (12) ++ ++ ++ ++ ++ ++
C62 2 (7) ++ ++ ++ +
C64 2 (6) ++ + + ++
C02 2 (5) ++ ++ +
C20 3 (4) + + ++
C41 3 (3) + ++
C83 3 (0)
C84 3 (0)
The behaviors were graded as either being overt (++) or only weakly perceptible (+). Blank cells indicate that the behavior was not present. Based on these behaviors,
we classified the stimulus as being highly effective in generating responses (1), moderately effective in generating responses (2), or ineffective (3). The later category
includes two animals (C83 and C84) that served as unstimulated controls. A score sum was generated by assigning a score of 2 to overt symptoms (++), and a score of 1
to weak symptoms (+).
doi:10.1371/journal.pone.0086730.t002
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ergic neurons in animal C62. Following a qualitative review of the
sections, counts of the number of Fos-immunopositive neurons
were obtained from the following areas having a high density of
labeling in a subset of animals: inferior vestibular nucleus, medial
vestibular nucleus (caudal and rostral aspects), lateral vestibular
nucleus (dorsal and ventral divisions), superior vestibular nucleus
(lateral and medial aspects), NTS (lateral, medial, and commis-
sural nuclei), periaqueductal gray (dorsal, lateral, ventral, and
ventrolateral divisions), parabrachial nucleus complex (medial and
lateral parabrachial nuclei and the adjacent Ko¨lliker-Fuse
nucleus), locus coeruleus, the subtrigeminal nucleus (region ventral
to the spinal trigeminal nucleus), the external cuneate nucleus, and
the subdivisions of the raphe nuclei. Because there was no
significant difference between the number of labeled cells in any
structure on the left versus right side, the total number of labeled
cells was used for principal component analysis. Since the raphe
nuclei contained many Fos-immunopositive neurons in some
animals, we performed dual-labeling immunohistochemistry on an
additional well of tissue from all animals except the unstimulated
controls to co-localize Fos and TPH2; examples of dual-labeled
cells are illustrated in Fig. 4, as well as Fig. S1.
Correlations between Fos Labeling and Symptoms
The numbers of Fos labeled neurons in a subset of the sampled
brain regions showed a strong positive correlation with both the
total symptom severity score and a subscore for autonomic
manifestations of motion sickness (subscore for frequent licking,
retching, excessive salivation, vocalization, panting, defecation
during the stimulation session, urination during the stimulation
session, and sedation [sleeping during the majority of the
stimulation session]) (Table 3). The positive correlation was strong
in the medial, lateral and inferior vestibular nuclei, but a weak
negative correlation was present in the superior vestibular nucleus.
The correlation was also strong in medial and lateral subnuclei of
the solitary nucleus, but not significant in the commissural solitary
nucleus. Strong positive correlations were also observed with Fos
labeling in locus coeruleus, Ko¨lliker-Fuse nucleus, non-serotoner-
gic cells (i.e., cells that were not immunopositive for TPH2) in the
nucleus raphe magnus and the medial and lateral parabrachial
nuclei, but not in the serotonergic (TPH2-immunopositive) cells in
the raphe nuclear groups, subtrigeminal nucleus, or any division of
the periaqueductal gray. There was a weak negative correlation
between the number of labeled cells and symptom severity in the
dorsal raphe nucleus and the raphe pallidus et obscurus. Stepwise
multiple regression (removal criterion p= 0.15) indicated that the
motion sickness symptom score could be represented (adjusted
multiple r-squared= 0.653) as a weighted sum of the number of
labeled cells in lateral subnucleus of the nucleus of the solitary tract
(coefficient: 0.123), subtrigeminal nucleus (coefficient: 0.143) and
external cuneate nucleus (coefficient: 0.033) plus a constant term
(21.567). The subscores for autonomic manifestations of motion
sickness showed a more robust regression result (adjusted multiple
r-squared= 0.951) as a weighted sum of the number of labeled
cells in the Ko¨lliker-Fuse nucleus (coefficient: 0.119) and
Figure 1. Locations of Fos-labeled neurons in two animals exhibiting strong symptoms of motion sickness (response type 1) during
galvanic vestibular stimulation. Neuronal locations were plotted on photomontages of sections taken using a 4X objective. Sections (A, E) are
from animal C52, whereas (B–D) are from animal C39. The sections were located at the following approximate distances posterior to stereotaxic zero,
in accordance with Berman’s atlas [85]: A, 13.5 mm; B, 10 mm; C, 9 mm; D, 7 mm; E, 3 mm. Abbreviations: BC, brachium conjunctivum; CN, cochlear
nuclei; DMV, dorsal motor nucleus of the vagus; DRNL, lateral division of dorsal raphe nucleus; DRNM, medial division of dorsal raphe nucleus; EC,
external cuneate nucleus; G, genu of facial nerve; IO, inferior olivary nucleus; LRN, lateral reticular nucleus; PBN, parabrachial nucleus; PH, prepositus
hypoglossi; RB, restiform body; RM, raphe magnus; RO, raphe obscurus; RP, raphe pallidus; SNV, spinal trigeminal nucleus; STN, subtrigeminal nucleus;
STV, spinal trigeminal tract; VI, abducens nucleus; VII, facial nucleus; VIN, inferior vestibular nucleus; VLD, dorsal division of lateral vestibular nucleus;
VLV, ventral division of lateral vestibular nucleus; VMN, medial vestibular nucleus; XII, hypoglossal nucleus.
doi:10.1371/journal.pone.0086730.g001
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subtrigeminal nucleus (coefficient: 20.088) plus a constant term
(20.398).
Principal Component Analysis: Identifying Connected
Network-like Behavior from Fos Data
The range of behavioral responses provides an opportunity for
identifying interconnected neural response networks from func-
tional correlations between Fos labeling in different nuclei in the
animals. The relationships between labeling across nuclei were
identified with an approach from principal component analysis, a
multivariate technique that was developed initially by Hotelling
[87] to identify a smaller number of independent variables that
can determine the values of observations from a larger number of
correlated independent variables. From a practical perspective, it
provides criteria to identify statistically independent, linear
combinations (principal components) of the measured variables
that explain the majority of the variance in the data [88]. Network
contributions of different nuclei can then be identified by shared,
high loadings on a particular component.
Results of principal component analysis of data from twelve
nuclear groups, plus serotonergic and non-serotonergic dorsal
raphe nucleus cells, are summarized in Table 3. The Kaiser-
Meyer-Olkin statistic of 0.74 and significant Bartlett’s test for
sphericity (p,0.05) indicated that the sample was adequate for the
principal component analysis [89]. Four orthogonal principal
components (eigenvalues: 8.062, 2.924, 1.724, and 1.009) were
identified. These statistically independent components are ex-
pressed as component loadings for each of the brain regions; the
loadings represent the relationship (on a range between 21 and 1)
between the component and the normalized (z-transformed)
labeling in that region. The polarities are arbitrary; opposite
polarities indicate a ‘push-pull’ relationship. For a given factor,
large magnitude loadings for different nuclei represent the strength
of the linear relationship of Fos labeling to that component. If a
group of structures is part of a known connected pathway, then
large magnitude loadings across those structures are consistent
with engagement of that network.
Component 1 (explains 34.99% of the variance) had large
positive loadings for the inferior vestibular nucleus, medial
vestibular nucleus, lateral vestibular nucleus, periaqueductal gray,
solitary nucleus, locus coeruleus and medial parabrachial nucleus,
and a weaker positive loading from the Ko¨lliker-Fuse nucleus.
Component 2 included large positive contributions from the
solitary nucleus, inferior vestibular nucleus, Ko¨lliker-Fuse nucleus,
and lateral parabrachial nucleus, with an opposite polarity
contribution from serotonergic dorsal raphe cells. Component 3
had large contributions from the superior vestibular nucleus,
periaqueductal gray, external cuneate nucleus and the subtrigem-
inal nucleus. Finally, Component 4 had a strong contribution from
non-serotonergic dorsal raphe neurons, with a lesser contribution
from serotonergic dorsal raphe cells and a contribution of opposite
polarity from the medial PBN. A principal components analysis
that included nuclear subdivision and other raphe nuclei (Table 4)
indicated that five principal components (eigenvalues of 12.263,
Figure 2. Locations of Fos-labeled neurons in the two unstimulated control animals (C83 and C84). Neuronal locations were plotted on
photomontages of sections taken using a 4X objective. Sections (A, B, E) are from animal C83, whereas (C, D) are from animal C84. The sections were
located at the following approximate distances posterior to stereotaxic zero, in accordance with Berman’s atlas: A, 13.5 mm; B, 12 mm; C, 8 mm; D,
6 mm; E, 4 mm. Abbreviations are the same as in Fig. 1, with the following additions: 5M, motor trigeminal nucleus; 5P, principal trigeminal nucleus;
LC, locus coeruleus; S, solitary nucleus; SO, superior olivary nucleus; SVN, superior vestibular nucleus.
doi:10.1371/journal.pone.0086730.g002
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6.011, 3.81, 2.61 and 1.307) could account for greater than 95% of
the variance in Fos labeling. Four of the components correspond
to the results of the analysis in Table 3 and have been named
identically.
The first component (Component 1 in Table 4) corresponds to
an anatomical refinement of Component 1 from the initial analysis
(Table 3). Large positive loadings were observed for most
vestibular nucleus divisions (except the superior vestibular
nucleus), the lateral subnucleus of the solitary nucleus, medial
parabrachial and Ko¨lliker-Fuse nuclei and (in decreasing order)
the dorsal, lateral, ventrolateral and ventral divisions of the
periaqueductal gray. It also has very high loading for the locus
coeruleus, but very low loadings for the dorsal raphe and nucleus
raphe magnus. It accounts for 31.2% of the between-animal
variance in the data. The normalized component scores showed a
positive correlation (r2 = 0.387) with the cumulative behavioral
scores and with the cumulative autonomic subscores (r2 = 0.53).
Component 2 in Table 4 corresponds to a refinement of
Component 2 from the initial analysis presented in Table 3. It
reflects push-pull interactions between two subnetworks. One
subnetwork reflects strong factor loadings with Fos expression in
the lateral parabrachial nucleus, medial subnucleus of the solitary
tract, and nucleus raphe magnus (both serotonergic and non-
serotonergic cells) as well as more moderate loadings from the
Ko¨lliker-Fuse nucleus, inferior vestibular nucleus, and lateral
subnucleus of the solitary tract. A contribution of opposite polarity
comes from serotonergic cells in the dorsal raphe nucleus.
Component 2 accounts for 20.5% of the between-animal variance
Figure 3. Photomicrographs of Fos-labeled neurons in a response type 1 animal (C52). In each row, a rectangular box on the left diagram
(generated from photomontages of sections taken using a 4X objective) shows the region depicted at higher magnification to the right. Scale bars on
the right photomicrographs designate 500 mm. A, Fos labeling in nucleus tractus solitarius, approximately 13.5 mm posterior to stereotaxic zero. B,
Fos labeling in the rostral portion of the medial vestibular nucleus, approximately 6 mm posterior to stereotaxic zero. C, Fos labeling in the
periaqueductal gray, approximately 3 mm rostral to stereotaxic zero. Abbreviations are the same as in Figs. 1–2, with the following additions: III,
oculomotor nucleus; MR, magnocellular portion of the red nucleus; PAG, periaqueductal gray; SC, superior colliculus.
doi:10.1371/journal.pone.0086730.g003
Motion Sickness Circuitry
PLOS ONE | www.plosone.org 7 January 2014 | Volume 9 | Issue 1 | e86730
in the data. The normalized component scores were uncorrelated
(r2 = 0.141) with the cumulative behavioral scores and with the
autonomic subscores (r2 = 0.018).
Component 2a reflects a moderate positive loading from the
Ko¨lliker-Fuse nucleus, with contributions of opposite polarity from
a network that includes strong influences of the serotonergic and
non-serotonergic cells in the nuclei raphe pallidus et obscurus and
the medial aspect of the superior vestibular nucleus, with more
moderate contributions from the lateral aspect of the superior
vestibular nucleus and external cuneate nucleus. It accounts for
15.7% of the variance. The normalized component scores were
uncorrelated (r2 = 0.04) with the cumulative behavioral scores and
with the autonomic subscores (r2 = 0.002). It appears to have been
embedded in components 2–4 of the initial analysis, primarily by
the pooling of the medial and lateral superior vestibular nucleus.
Component 3 in Table 4 corresponds to an anatomical
refinement of component 3 from the initial analysis. It has large
positive loadings for the subtrigeminal nucleus, lateral aspect of the
superior vestibular nucleus, external cuneate nucleus, and the
ventral and ventrolateral divisions of the periaqueductal gray, and
moderate loadings from the medial parabrachial nucleus, lateral
subnucleus of the periaqueductal gray and non-serotonergic
neurons in nuclei raphe pallidus et obscurus. The serotonergic
dorsal raphe neurons have a relatively strong loading of opposite
polarity. Factor 4 accounts for 17.3% of the between-animal
variance. Normalized component scores showed a positive
correlation (r2 = 0.35) with the cumulative behavioral scores and
with the autonomic subscores (r2 = 0.325).
Finally, Component 4 in Table 4, an anatomical refinement of
Component 4 of the initial analysis, has high loadings (negative
polarity) for non-serotonergic cells in the dorsal raphe nucleus,
commissural subnucleus of the solitary nucleus, and the dorsal
region of the periaqueductal gray, with more moderate loadings
for the medial aspect of the superior vestibular nucleus (the
terminus of periventricular plexus (small caliber) non-serotonergic
dorsal raphe axons) and serotonergic cells in nucleus raphe
magnus. Component 5 accounts for 15.2% of the between-animal
variance. The normalized component scores among animals were
uncorrelated (r2 = 0.080) with the cumulative behavioral scores
and with the autonomic subscores (r2 = 0.125).
Figure 4. Photomicrograph illustrating examples of neurons
that were immunopositive for Fos (solid black arrows), TPH-2
(solid gray arrows) and both TPH-2 and Fos (open arrow). A
rectangular box on the inset diagram indicates the region of the dorsal
raphe nucleus depicted in the photomicrograph. The scale bar
represents 250 mm.
doi:10.1371/journal.pone.0086730.g004
Table 3. Correlation of labeling with symptom score and component loadings from principal component analysis with equamax
rotation.
Structure
Correlation re: Signs,
Total (Autonomic only) Component 1 Component 2 Component 3 Component 4
Lateral Vestibular N. 0.879 (0.886) 0.901 0.305 0.074 0.297
Medial Vestibular N. 0.715 (0.680) 0.926 0.287 0.201 0.136
Locus Coeruleus 0.874 (0.844) 0.861 0.248 0.084 0.434
Periaqueductal N. 0.145 (0.056) 0.856 0.091 20.504 20.001
Nucleus Tractus Solitarius 0.647 (0.600) 0.687 0.698 0.134 0.001
Inferior Vestibular N. 0.784 (0.789) 0.672 0.545 0.076 0.493
Medial Parabrachial N. 0.710 (0.702) 0.636 0.440 20.255 0.580
Ko¨lliker-Fuse N. 0.901 (0.947) 0.538 0.630 0.309 0.447
Lateral Parabrachial N. 0.785 (0.786) 0.006 0.967 0.213 0.132
Dorsal Raphe N. (TPH2) 20.395 (20.430) 20.359 20.612 0.422 20.517
Superior Vestibular N. 0.487 (0.476) 20.068 20.329 20.815 20.468
External Cuneate 0.392 (0.371) 20.060 20.260 20.951 0.075
Subtrigeminal N. 0.450 (0.500) 20.020 0.334 20.732 0.468
Dorsal Raphe N. (non-TPH2) 20.23 (20.316) 20.015 20.029 0.007 20.990
% Variance explained 34.99% 22.98% 20.15% 19.87%
r2 of Score re: Signs 0.41 (0.29) 0.26 (0.29) 0.26 (0.31) 0.05 (0.11)
Bold type is used to highlight regions with strong negative or positive correlations between the number of Fos-immunopositive neurons and symptom severity scores.
Bold type also designates large positive component loadings; bold and italicized type designates negative component loadings. TPH2: Tryptophan hydroxylase 2, a
marker of brain serotoninergic neurons.
doi:10.1371/journal.pone.0086730.t003
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Discussion
The nuclear expression of the early immediate gene
transcription factor Fos has been used for several decades to
identify neurons affected by a variety of peripheral and central
stimuli [29,90]. For example, Fos expression patterns can be
used as a marker of anatomically and physiologically identified
pain and autonomic pathways in different contexts [91–95].
The brain stem structures that were selected for Fos quantifi-
cation have been implicated in either (1) vestibular contribu-
tions to autonomic, affective and somatic pathways [96,97], (2)
Fos activation by vestibular stimulation [98] or (3) generation of
nausea, emesis and responses to noxious stimulation
[22,27,91,92], and include both the raphe nuclei and locus
coeruleus. These structures have also shown Fos activation after
both natural vestibular stimulation [99,100] and acute unilateral
vestibular damage [101].
Principal component analysis is an exploratory multivariate
statistical approach to identify a reduced set of orthogonal
principal components that account for the variability in a larger
data set of many measured variables [88,102]. This approach
was pioneered in the early 1930s by Hotelling [87]. From a
mathematical perspective, principal components are the char-
acteristic vectors of the covariance or the correlation matrix of a
data set. Principal components are linear combinations of
measured variables that have large variances and, therefore, can
account for the variation in the data in terms of positive and
negative interactions among the measurements. Hence, the
approach is suited well for identifying presumptive interactions
between groups of neurons (measured variables such as cFos
labeling) contributing to functional pathways (principal compo-
nents).
The experiment was designed explicitly to facilitate the use of
principal component analysis for identifying functional pathways
on the basis of synchronous Fos expression during the
generation of behaviors culminating in motion sickness. Firstly,
existing knowledge regarding vestibular and autonomic path-
ways permits ‘sense-making’ by associating the identified
principal components with neuronal networks. By sampling
cFos labeling from nuclei that contribute to known networks for
processing vestibular and autonomic information, the contribu-
tions of neuronal populations to individual principal components
Table 4. Correlation of labeling with symptom score and component loadings from principal component analysis with equamax
rotation, with nuclear subdivisions included.
Structure
Correlation re:
Symptoms, Total
(Autonomic only) Component 1 Component 2 Component 2a Component 3 Component 4
Dorsal Lateral Vestibular N. 0.742 (0.757) 0.934 0.184 0.12 0.261 20.108
Rostral Medial Vestibular N. 0.726 (0.673) 0.929 0.176 0.269 0.154 20.099
Caudal Medial Vestibular N. 0.687 (0.662) 0.872 0.346 0.321 20.081 0.096
Locus Coeruleus 0.874 (0.844) 0.85 0.292 0.25 0.135 0.334
Lateral Periaqueductal Gray 0.202 (0.120) 0.837 0.019 20.095 0.537 0.031
Ventral Lateral Vestibular N. 0.780 (0.773) 0.826 0.361 0.321 0.087 0.278
Lateral Nucleus Tractus Solitarius 0.652 (0.601) 0.764 0.55 0.16 20.203 0.219
Dorsal Periaqueductal Gray 0.082 (20.009) 0.734 0.048 20.022 0.102 20.67
Ventrolateral Periaqueductal Gray 0.115 (0.074) 0.738 0.101 0.127 0.65 0.083
Inferior Vestibular N. 0.784 (0.789) 0.635 0.527 0.398 0.241 0.321
Ventral Periaqueductal Gray 0.079 (20.129) 0.614 0.007 20.409 0.674 20.034
Medial Parabrachial N. 0.710 (0.702) 0.606 0.428 0.185 0.509 0.395
Ko¨lliker2Fuse N. 0.901 (0.947) 0.491 0.584 0.58 0.067 0.276
Lateral Parabrachial N. 0.785 (0.786) 20.056 0.929 0.363 0.039 0.005
Raphe Magnus (non-TPH2) 0.492 (0.467) 0.171 0.894 0.3 20.253 0.137
Medial Nucleus Tractus Solitarius 0.652 (0.635) 0.27 0.873 0.128 0.273 0.271
Raphe Magnus (TPH2) 0.096 (0.066) 20.167 0.751 0.28 20.079 20.569
Dorsal Raphe Nucleus (TPH2) 20.395 (20.43) 20.331 20.641 0.049 20.585 20.367
Raphe Pallidus/Obscurus (TPH2) 20.359 (20.487) 0.085 20.262 20.951 20.102 0.097
Raphe Pallidus/Obscurus (non2TPH2) 20.450 (20.538) 20.432 0.081 20.753 0.489 0.019
Medial Superior Vestibular N. 0.502 (0.495) 20.029 20.428 20.689 0.108 20.575
External Cuneate 0.392 (0.371) 20.044 20.266 20.611 0.744 0.029
Lateral Superior Vestibular N. 0.454 (0.442) 20.079 20.253 20.545 0.733 20.308
Subtrigeminal N. 0.450 (0.500) 20.077 0.118 0.157 0.964 0.161
Commissural Nucleus Tractus Solitarius 20.051 (20.100) 0.062 20.037 0.07 0.075 20.992
Dorsal Raphe N. (non-TPH2) 20.230 (20.316) 20.042 20.104 20.15 20.25 20.95
Bold type is used to highlight regions with strong negative or positive correlations between the number of Fos-immunopositive neurons and symptom severity scores.
Bold type also designates large positive component loadings; bold and italicized type designates negative component loadings. TPH2: Tryptophan hydroxylase 2, a
marker of brain serotoninergic neurons.
doi:10.1371/journal.pone.0086730.t004
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can be interpreted in terms of network activity. Secondly,
because the data set consisted of individual experimental
animals displaying different degrees (manifestations) of motion
sickness, the components across the population provide an
estimate of activity in the associated networks across the
behavioral response spectrum. Hence, the approach exploits
the individual variation in the severity of behavioral motion
sickness to identify co-modulated neuronal pathways as principal
components that explain underlying variance in the Fos
labeling. It is analogous to strategies for identifying synchronous,
connected networks from electrophysiological [103] or function-
al imaging data [104]. Therefore, the five components identified
by this approach represent coordinated engagement of pathways
along the progression from mild discomfort to emesis.
Components 1 and 4 showed a positive correlation with the
cumulative behavioral scores, especially with the autonomic
subscore. Hence, they are likely related to the overt signs of
motion sickness reflected in the behaviors monitored in this
study. Component 1 reflects correlates of changes in vestibular
nucleus Fos activation during galvanic vestibular stimulation.
The factor is anchored by the strong covariance in Fos
activation within locus coeruleus, vestibular nuclei, lateral
NTS, medial parabrachial nucleus and periaqueductal gray,
and a more moderate relationship with the Ko¨lliker-Fuse
nucleus. Because anatomical studies have documented direct,
strong interconnections among these structures, the Fos co-
regulation represents coordinated engagement of this network
across animals with different levels of behavioral responses to
galvanic (or sham) stimulation. Locus coeruleus receives direct
projections from the vestibular nuclei [105,106] and its neurons
respond to both vestibular and neck stimulation [107]. Locus
coeruleus also contributes a regionally specialized projection to
the vestibular nuclei [108]. The medial parabrachial nucleus is
connected reciprocally with the vestibular nuclei [105,109]; the
lateral NTS receives direct input from the vestibular nuclei
[51,110] and projects to the external medial parabrachial and
Ko¨lliker-Fuse nuclei [111]. The periaqueductal gray receives
light projections from the vestibular nuclei [112], is connected
reciprocally with the locus coeruleus [113,114], and projects to
the medial and lateral parabrachial nuclei [115]. Recent studies
in rats indicate that Fos activation in locus coeruleus and the
periaqueductal gray is observed in animals displaying escape
responses in an elevated T-maze task [116], which may include
recruitment of anxiolytic effects of norepinephrine via the dorsal
periaqueductal gray [117].
Component 3, like Component 1, identifies correlated Fos
labeling in a network involving interconnections between the
periaqueductal gray and medial parabrachial nucleus [115].
However, unlike Component 1, it has negligible association with
Fos labeling in the lateral, medial and inferior vestibular nuclei.
Rather, the labeling is associated with Fos activation in the lateral
aspect of the superior vestibular nucleus and two precerebellar
regions that are activated by prolonged, natural linear acceleration
(otolith organ) stimuli, the subtrigeminal and external cuneate
nuclei [98]. The positive association of Fos labeling in non-
serotonergic raphe pallidus et obscurus neurons is also of opposite
polarity to the contribution to Component 1, and the serotonergic
dorsal raphe labeling has a loading similar to Component 2. Thus,
this Fos activation may reflect the fact that the lateral aspect of the
superior vestibular nucleus receives large caliber serotonergic
dorsal raphe nucleus projections, but negligible non-serotonergic
inputs from the dorsal raphe nucleus via periventricular plexus
[118].
A Fos coactivation of cells in the lateral periaqueductal gray and
dorsal raphe nucleus was noted recently in association with
avoidance responses to an elevated T-maze task [116] and during
defensive behaviors in rodents [119]. Finally, the correlated
periaqueductal gray and subtrigeminal nucleus contributions are
of interest in light of similar activation in imaging studies during
offset analgesia [120]. We suggest that this network is reflects
responses to aversive aspects of visuospatial discomfort and
anxiety.
Components 2, 2a, and 4 were uncorrelated with the
cumulative behavioral scores, and thus were not related to the
overt signs of motion sickness. Instead, these factors were likely
related to the covert symptoms of motion sickness that are not
readily evident (e.g., affective components of the condition).
Component 2 reflects interactions of opposite polarity from two
interconnected networks related to nucleus raphe magnus and
the serotonergic cells in the dorsal raphe nucleus, respectively.
Strong positive factor loadings for Fos labeling were identified in
a network of structures that are interconnected with serotoner-
gic and non-serotonergic cells of nucleus raphe magnus [121–
125], including strong loadings for the lateral parabrachial
nucleus and medial subnucleus of the solitary tract and more
moderate, positive loadings for labeling in the medial para-
brachial nucleus, Ko¨lliker-Fuse nucleus, inferior vestibular
nucleus, and lateral subnucleus of the solitary tract. This Fos
activity likely reflects interconnections between the inferior
vestibular nucleus, Kolliker-Fuse nucleus and nuclei of the
solitary tract [51,105,109,111,126]. These interconnections are
likely involved in generation of discharges of serotonergic
nucleus raphe magnus neurons in association with autonomic
and respiratory activity [127]. Contributions of opposite polarity
are provided by Fos labeling of serotonergic cells in the dorsal
raphe nucleus, and, to a more moderate extent, from the
medial aspect of the superior vestibular nucleus, which receives
serotonergic input from the dorsal raphe nucleus [118]. Because
several structures had significant positive loadings on this
component, and nucleus raphe magnus and the medial and
lateral subnuclei of the solitary nucleus provide inputs to the
dorsal raphe nucleus [128], this component suggests a prom-
inent push-pull interplay between raphe magnus and dorsal
raphe circuits in the development of autonomic and respiratory
components of nausea and emesis. More significantly, they likely
reflect the role of nucleus raphe magnus neurons in descending
modulation of sensitivity to aversive visceral and somatic sensory
information [129], analogous to its role in maintenance of
hyperalgesia and allodynia after nerve injury and inflammation
[130].
Component 2a reflects an opposite relationship between Fos
activation in the Ko¨lliker-Fuse nucleus and concurrent Fos
inhibition in a network that includes serotonergic and non-
serotonergic cells in the nuclei raphe pallidus et obscurus, neurons
in the superior vestibular nucleus and external cuneate nucleus.
Although Fos labeling in each of the latter structures is correlated
negatively with symptom score (Table 4), the factor scores were
uncorrelated with the magnitude of the symptom score. The
relationships between Fos labeling in the caudal raphe nuclei,
superior vestibular nucleus and Ko¨lliker-Fuse nucleus in Compo-
nent 2a are statistically independent of the relationships between
the latter structures and more rostral raphe nuclei in Component
2, which is suggestive of different functions. Both the Ko¨lliker-Fuse
and superior vestibular nuclei project to raphe pallidus et obscurus
[122] and these caudal raphe nuclei contribute serotonergic and
non-serotonergic projections to the vestibular nuclei [131]. A
recent optogenetic study [132] reported that activation of
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serotonergic neurons in raphe obscurus increased respiratory
amplitude and frequency as well as the sensitivity of central
respiratory chemoreflexes. The caudal raphe nuclei have also been
implicated as a modulator of other somatosympathetic responses,
including cardiovascular sympathoexcitatory reflexes during acu-
puncture [133]. Hence, the network contributing to this factor
may be modulating respiratory and autonomic motor activity
associated with the magnitude of development of motion sickness
signs.
Component 5 is anchored by high magnitude contributions
from Fos labeling in the commissural nucleus tractus solitarii and
non-serotonergic dorsal raphe neurons and moderate loadings
from the dorsal periaqueductal gray, serotonergic neurons in the
nucleus raphe magnus and the medial aspect of the superior
vestibular nucleus. This activity may reflect a network anchored by
commissural nucleus tractus solitarii projections to the dorsal
raphe nucleus [128] and non-serotonergic dorsal raphe projections
to the medial aspect of the superior vestibular nucleus [118]. The
serotonergic raphe magnus contribution may also reflect its
afferent relations with the periaqueductal gray [134] and strong
projections to nucleus tractus solitarii [123]. Because activation the
dorsal periaqueductal gray contributes to aversion and anxiety-like
responses [135], we suggest this network is involved in generation
of integrated vestibular-visceral aversive signals related to motion
sickness.
The principal component analysis approach also highlighted
several striking global relationships for Fos activation patterns in
the locus coeruleus (noradrenergic), and the serotonergic and
non-serotonergic cell groups in the dorsal raphe nucleus,
nucleus raphe magnus and nuclei raphe pallidus et obscurus.
Specifically, different combinations of these groups were
associated with different statistically independent components.
Firstly, locus coeruleus Fos labeling patterns are independent
statistically from Fos labeling of serotonergic neurons in the
dorsal raphe, raphe magnus and raphe pallidus et obscurus.
Secondly, the Fos labeling of serotonergic and non-serotonergic
dorsal raphe nucleus cells tend to behave independently, which
suggests that their differential projections to the vestibular nuclei
and ascending pathways [118] are associated with different roles
in responses to galvanic stimulation leading to autonomic
arousal. Thirdly, reciprocal (push-pull) relationships between
these different cell groups were prominent in three of the
factors: locus coeruleus versus nuclei raphe pallidus et obscurus
for Component 1, serotonergic and non-serotonergic nucleus
raphe magnus neurons versus serotonergic dorsal raphe nucleus
neurons for Component 2, and serotonergic dorsal raphe
neurons versus non-serotonergic raphe pallidus et obscurus
neurons on Component 4. Finally, Component 5 featured
parallel Fos labeling of serotonergic nucleus raphe magnus and
non-serotonergic dorsal raphe nucleus neurons.
Summary and Conclusions
The identification of five statistically independent component
networks associated with the development of motion sickness
provides an opportunity to consider, in network activation
dimensions, the complex progression of signs and symptoms that
are precipitated in provocative environments (both real and
virtual). The inability of numerous studies to identify autonomic
pathognomonic patterns during the development of motion
sickness [136] leave us to rely on subjective symptoms and
symptom clusters. Hence, it will be important to determine the
relationships between temporal patterns of activity in these
networks and the behavioral and perceptual dimensions used to
assess the severity of motion sickness. In essence, this approach
may allow us to formulate motion sickness in terms of General
Recognition Theory [137], by framing the component networks
as orthogonal dimensions (processes) that produce progressive,
perceptually independent clusters of signs and symptoms.
Schemata for the dimensions underlying subjective signs and
symptoms of motion sickness have been derived from multivar-
iate analysis of responses to questionnaires [138,139]. For
example, the Simulator Sickness Questionnaire (SSQ) scoring
metric was constructed from a principal component analysis of
the original Pensacola Motion Sickness Questionnaire [138].
The authors identified orthogonal dimensions that they termed
nausea (and/or gastrointestinal awareness), vision and visuomo-
tor (eyestrain) function, and disorientation (dizziness, blurred
vision and difficulty focusing) which have been used to
document psychophysical differences in responses to different
visual environments, simulator types, and stimulus patterns in
vection drums [140]. A more recent Motion Sickness Assess-
ment Questionnaire (MSAQ) is based upon four factors
identified from a broader, two phase exploratory analysis
[141]. The MSAQ gastrointestinal factor spans sensations from
queasiness to nausea and vomiting. The MSAQ central factor
includes dizziness, lightheadedness, disorientation and blurred
vision. The MSAQ peripheral factor includes reports associated
with autonomic responses such as sweatiness, clamminess, and
hot/warm sensations. Finally, the MSAQ sopite-like factor
captures diffuse fatigue, affective and emotional components
associated with the ‘sopite syndrome’ [142,143]. Because these
questionnaire-based factors are only clusters of correlated
symptoms, their relationship to metrics of activation of the
networks identified in this study (e.g., from functional imaging
studies) has the potential to bring etiologic precision to the
diagnosis of prodromal trajectories of motion sickness.
The networks identified in this study include component
pathways that have been described in the pain literature as
subserving the affective dimension(s) of pain [144], particularly
interoception and generation of feelings and emotions associated
with activity in nociceptive afferent pathways [145–147]. In a
broader sense, this overlap of networks for a pain and motion
sickness is consistent with their role in core circuitry for
determining the aversiveness of sensory patterns [148]. These
networks also are likely contributors to the affective and
emotional process of ‘being in pain’, which, as noted in 1968
by Melzack and Casey [149] and elaborated later by Grahek
[150], can be dissociated from pain sensation and perception.
Psychophysical studies have attempted to separate pain sensa-
tion and perception from pain aversiveness by asking subjects to
rate both intensity and unpleasantness. It is of interest that for
visceral and somatic pain stimuli of equal estimated intensity,
the visceral pain is judged to be significantly more unpleasant
[151]. Hence, activity in the five networks identified in our
study may contribute to the aversive aspects of the development
of motion sickness.
Supporting Information
Figure S1 Plate comparing TPH2 and Fos labeling in three
brain areas of animal C62: Dorsal raphe nucleus (A), Raphe
magnus (B), and raphe pallidus (C). The calibration bar in this
plate represents 500 mA in A and 250 mA in B–C.
(TIF)
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